NI
ATRS

Numeric Investors’s Antares Pharma, Inc. ATRS Stock Holding History

Numeric Investors’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-75,700
Closed -$129K – 1170
2015
Q3 		$129K Buy
+75,700
New +$148K ﹤0.01% 947
2014
Q2 		– Sell
-18,900
Closed -$66K – 943
2014
Q1 		$66K Buy
+18,900
New +$83.9K ﹤0.01% 761

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors's ATRS Position: Q4 2015 in Review

Numeric Investors sold out of Antares Pharma, Inc. (ATRS) in Q4 2015, closing a stake of 75,700 shares — an estimated $129K sold.

Numeric Investors first reported a position in ATRS in Q1 2014 and held it in 2 quarters. The position peaked at $129K in Q3 2015. 88 funds tracked by Wall St. Rank hold ATRS as of Q4 2015.

  • Numeric Investors reported no remaining Antares Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Numeric Investors sold 75,700 Antares Pharma, Inc. shares in Q4 2015, an estimated $129K.
  • Numeric Investors first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 2 quarters.
  • Numeric Investors's Antares Pharma, Inc. position peaked at $129K in Q3 2015.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2015.

Based on Numeric Investors's 13F filing for Q4 2015, filed 1 Feb 2016.